Summary: Overcoming complex blinding and masking challenges in clinical trials requires a balance of strategy and adaptability. When conducting clinical trials...

Summary: Formulating drugs for optimal stability and bioavailability is fundamental to the development of new pharmaceutical products. Once developed, these products must then be delivered...

Summary: Accelerating the flow of clinical supplies both into and out of China can be accomplished using a dual-supply site model. Learn how this approach leverages both...

Summary: No two studies are the same and each clinical supply project carries unique risks. Experienced supply chain managers know that certain study characteristics are often leading indicators that they can...

Summary: The traditional clinical supply model is a static, linear stock based approach that uses bulk storage to ship to depots based on anticipated demand. The supply for an entire clinical trial...

Summary: A short video on Catalent's flexible and innovative clinical supply services for phase 1-4 clinical trial sponsors. We have the deep expertise, global capabilities and...

Summary: Catalent understands there are numerous ways to approach the various facets of blinding drugs for use in a clinical trial. Employing the right blinding strategy can...

Summary: MGB Biopharma, a biotech company based in Scotland, U.K. was developing a new class of anti-infective medicine based on Minor Groove Binder compounds...

Summary: Biologic clinical trials can be complex with many factors to consider.  Understanding your specific needs and developing a plan early on during drug development can...

Summary: Clinical trials are conducted according to a protocol, which is the master action plan for how the study will be conducted. Clinical trial protocol design can have a significant impact on the sourcing...